RT @drdavidliew: Biosimilars are not just about savings. More manufacturers can mean innovation: better programs/devices

Social Author Image
https://pbs.twimg.com/profile_images/883609165922394112/i-2eHFGw.jpg
Tweet Author
drdavidliew
Social Author Name
David Liew
Tweet Content
Biosimilars are not just about savings. More manufacturers can mean innovation: better programs/devices pursuing new indications eg COVID sc formulations CT-P13 infliximab biosimilar: immunogenicity sc vs iv same. Particularly useful in pandemic times! #ACR20 ABST1208 @RheumNow https://t.co/WjJ6OOST55
Show on Archive Page
On
Display in Search Results
On

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright {{ 'now'|date('Y') }} All Rights Reserved.